Records containing: Peanut Allergy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-27A Double-blind Randomized Controlled Trial of 6-month of Abatacept vs Placebo as Adjuvant to Peanut Oral Immunotherapy to Induce Immunologic Changes in Patients With Severe Persistent Peanut Allergy
-
CLINICAL_TRIALS study record update · 2024-10-23A Phase 1, Randomized, Placebo Controlled Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA LAMP Vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
-
CLINICAL_TRIALS study record update · 2024-10-23A Phase 1, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
-
CLINICAL_TRIALS study record update · 2024-09-19Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy
-
CLINICAL_TRIALS study record update · 2024-06-04Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy (OIT) in Food Allergic Children and Adults (CoFAR-11)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-05-29A Single Arm Phase II Efficacy Study of Peanut Oral Immunotherapy in Adults
-
CLINICAL_TRIALS study record update · 2024-03-29Follow up of Learning Early About Peanut Allergy (LEAP) Participants and Their Families: LEAP Trio (ITN070AD)
-
CLINICAL_TRIALS study record update · 2024-02-08A Randomised, Controlled Trial Evaluating the Effectiveness of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Desensitisation or Remission in Chinese Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo
-
CLINICAL_TRIALS study record update · 2024-02-07A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
-
CLINICAL_TRIALS study record update · 2023-12-20A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2023-12-20Identification of Anaphylactogenic Antibodies in the Blood of Peanut Allergic Patients
-
CLINICAL_TRIALS study record update · 2023-12-06Pilot Study to Collect Blood From Research Subjects Allergic and Non-allergic to Peanut to Study Immune Modulation With Anti-IgE Therapy in Mice
-
CLINICAL_TRIALS study record update · 2023-12-05Assessing Tolerance to "May Contain Traces" Processed Foods in Tree Nuts or Peanut Allergic Children.
-
CLINICAL_TRIALS study record update · 2023-10-18VE416 and Low-dose Peanut Oral Immunotherapy for Treatment of Persistent Peanut Allergy
-
CLINICAL_TRIALS study record update · 2023-09-18A Two-Part 1b/2a Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2023-08-28Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
-
CLINICAL_TRIALS study record update · 2023-08-01Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy - Evaluation of Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2023-07-28Oral Mucosal Escalation Goal Assessment (OMEGA) Study: A Randomized Placebo-Controlled Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut
-
CLINICAL_TRIALS study record update · 2023-07-27Placebo-Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2023-04-19Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy
-
CLINICAL_TRIALS study record update · 2023-04-11Early Peanut Introduction: Translation to Clinical Practice
-
CLINICAL_TRIALS study record update · 2023-03-02Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)
-
CLINICAL_TRIALS study record update · 2023-01-30Salvage Peanut Oral Immunotherapy Study: A Single-arm, Open Label Trial of Peanut Flour With 6 Month Active Treatment and 6 Month Follow-up
-
CLINICAL_TRIALS study record update · 2022-06-30Open-label Follow-up Study of the VIPES Study to Evaluate Long-term Efficacy and Safety of the Viaskin Peanut
-
CLINICAL_TRIALS study record update · 2022-05-19A Study to Evaluate the Efficacy and Safety of Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy